Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy.
A FassioG PorcielloG CarioliE PalumboS VitaleA LuongoC MontagneseM PreteM GrimaldiR PicaE RotondoL FalzoneI CalabreseA MinopoliB GrilliM CuomoP C FiorilloC EvangelistaE CavalcantiM De LaurentiisD CiannielloC PacilioM PintoG ThomasM RinaldoM D'AiutoD SerrainoS MassarutA SteffanF FerraùR RosselloF MessinaF CatalanoG AdamiF BertoldoM LibraA CrispoE CelentanoC La VecchiaL S A AugustinD GattiPublished in: Reumatismo (2024)
Hypovitaminosis D in women recently diagnosed with BC and participating in a lifestyle trial in Italy was widespread and highest with obesity, hypertriglyceridemia, and chemotherapy use. Considering that hypovitaminosis D is a risk factor for lower efficacy of bone density treatments and possibly BC mortality, our results suggest the need to promptly address and treat vitamin D deficiency.
Keyphrases
- metabolic syndrome
- weight loss
- polycystic ovary syndrome
- study protocol
- phase iii
- insulin resistance
- clinical trial
- breast cancer risk
- pregnancy outcomes
- phase ii
- physical activity
- cardiovascular disease
- type diabetes
- cervical cancer screening
- cardiovascular events
- randomized controlled trial
- pregnant women
- risk factors
- locally advanced
- weight gain
- high fat diet induced
- newly diagnosed
- bone loss
- rectal cancer